Anti-Müllerian hormone and polycystic ovary syndrome: Assessment of the clinical pregnancy rates in in vitro fertilization patients

dc.contributor.author	Sahmay, S.
dc.contributor.author	Guralp, O.
dc.contributor.author	Aydogan, B.
dc.contributor.author	Cepni, I.
dc.contributor.author	Oral, E.
dc.contributor.author	Irez, T.
dc.date.accessioned	2021-12-21T08:41:52Z
dc.date.available	2021-12-21T08:41:52Z
dc.date.issued	2013
dc.identifier.issn	9513590
dc.identifier.uri	https://doi.org/10.3109/09513590.2013.769519
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1536
dc.description.abstract	Objective: The purpose of this study is to investigate the role of serum anti-Müllerian hormone (AMH), follicle-stimulating hormone (FSH) and antral follicle count (AFC) for the prediction of clinical pregnancy rates (CPR) in women with polycystic ovary s
dc.language.iso	English
dc.title	Anti-Müllerian hormone and polycystic ovary syndrome: Assessment of the clinical pregnancy rates in in vitro fertilization patients
dc.type	Article
dc.relation.journal	Gynecological Endocrinology
dc.identifier.issue	5
dc.identifier.startpage	440
dc.identifier.endpage	443
dc.identifier.volume	29
dc.identifier.doi	10.3109/09513590.2013.769519
dc.relation.issue	5
dc.relation.volume	29

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.